Pfizer Inc. and the Scripps Research Institute allege in a new lawsuit that a copy of Vyndamax proposed by Dexcel Pharma Technologies Ltd. infringes three patents for the blockbuster heart drug, an increasingly important source of Pfizer’s revenue.
Dexcel's Generic Pantoprazole Sodium Receives Approval in the U.S.
Par Pharma's Generic Isosorbide Dinitrate Receives Approval in the US
Dexcel Pharma's Generic Vigabatrin Receives Approval in the US
Dexcel Pharma`s Hemady (Dexamethasone) Receives Approval in US
Dexcel's Generic Isosorbide Mononitrate Receives Approval in US
Several heart drugs containing valsartan are being recalled in Europe after a Chinese active ingredient manufacturer found residues of a substance that could cause cancer in its supplies.
Perrigo and its Israel based partner, Dexcel Pharma announced the launch of store brand omeprazole delayed release orally disintegrating tablets 20mg (omeprazole ODT), an over-the-counter (OTC) medication to treat frequent heartburn.
(Omeprazole): Dexcel v. Apotex
Dexcel`s Lansoprazole approved in US for treatment of Ulcers